Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001235126-24-000044
Filing Date
2024-09-23
Accepted
2024-09-23 13:28:02
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A boos13dalexx083124.txt SC 13D/A 5195
  Complete submission text file 0001235126-24-000044.txt   6684
Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Subject) CIK: 0001348362 (see all company filings)

EIN.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: SC 13D/A | Act: 34 | File No.: 005-85256 | Film No.: 241315748
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 5260 N PALM AVENUE SUITE 120 FRESNO CA 93704
Business Address
Boos Wayne W (Filed by) CIK: 0001987877 (see all company filings)

Type: SC 13D/A